CEO: Simon Kerry

Advent Contact: Simon Kerry & Shahzad Malik

Next-generation functional drug discovery platform

Curve is transforming the discovery of new therapeutics through direct functional screening of genetically-encoded Microcycle libraries against targets in their native environment. Curve is using its platforms to develop a pipeline of first-in-class therapeutics against a number of challenging cancer targets, including intracellular protein-protein and protein-gene interactions.